AI Science Tracker
EN

Genistin: A Novel Estrogen Analogue Targeting ERβ to Alleviate Thrombocytopenia.

Affiliation not stated in the reviewed material · 25 Mar 2024 · multidisciplinary

Discovery

Genistin: A Novel Estrogen Analogue Targeting ERβ to Alleviate Thrombocytopenia.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Publisher full text/PDF Methods and Results show RF screening over 777 descriptors, followed by cell and mouse experiments on genistin; biological effects and ERβ-related mechanism are supported preclinically.

Technology: ML narrowed candidate search; genistin promoted megakaryocyte/platelet outcomes in vitro and improved radiation thrombocytopenia in mice. This is preclinical evidence, not clinical treatment efficacy.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
ML narrowed candidate search; genistin promoted megakaryocyte/platelet outcomes in vitro and improved radiation thrombocytopenia in mice. This is preclinical evidence, not clinical treatment efficacy.
Limitation / still unknown
Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.ijbs.com/v20p2236.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse multidisciplinary discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.